Application, Benefits, and Limitations of Telepharmacy for Patients with Diabetes in the Outpatient Setting

References

• Le T, Toscani M, Colaizzi J. Telepharmacy: a new paradigm for our profession. J Pharm Pract. 2020;33(2):176–182. doi:10.1177/0897190018791060
   PubMed Web of Science ®Google Scholar
• Taylor AM, Bingham J, Schussel K, et al. Integrating innovative telehealth solutions into an interprofessional team-delivered chronic care management pilot program. J Manag Care Spec Pharm. 2018;24(8):813–818. doi:10.18553/jmcp.2018.24.8.813
   PubMed Web of Science ®Google Scholar
• Casey MM, Sorensen TD, Elias W, Knudson A, Gregg W. Current practices and state regulations regarding telepharmacy in rural hospitals. Am J Health Pharm. 2010;67:13. doi:10.2146/ajhp090531
   Web of Science ®Google Scholar
• Keeys C, Kalejaiye B, Skinner M, et al. Pharmacist-managed inpatient discharge medication reconciliation: a combined onsite and telepharmacy model. Am J Health Pharm. 2014;71(24). doi:10.2146/ajhp130650
   PubMed Web of Science ®Google Scholar
• Sankaranarayanan J, Murante LJ, Moffett LM, Retrospective A. Evaluation of remote pharmacist interventions in a telepharmacy service model using a conceptual framework. Telemed E Health. 2014;20(10). doi:10.1089/tmj.2013.0362
   Web of Science ®Google Scholar
• Win AZ. Telepharmacy: time to pick up the line. Res Soc Adm Pharm. 2017;13(4):882–883. doi:10.1016/j.sapharm.2015.06.002
   PubMed Web of Science ®Google Scholar
• Iftinan GN, Wathoni N, Lestari K. Telepharmacy: a potential alternative approach for diabetic patients during the COVID-19 pandemic. J Multidiscip Healthc. 2021;14:2261–2273. doi:10.2147/JMDH.S325645
   PubMed Web of Science ®Google Scholar
• Di Cerbo A, Morales-Medina JC, Palmieri B, Iannitti T. Narrative review of telemedicine consultation in medical practice. Patient Prefer Adherence. 2015;9:65–75. doi:10.2147/PPA.S61617
   PubMed Web of Science ®Google Scholar
• Bynum A, Hopkins D, Thomas A, Copeland N, Irwin C. The effect of telepharmacy counseling on metered-dose inhaler technique among adolescents with asthma in rural Arkansas. Telemed J E Health. 2001;7(3):3. doi:10.1089/153056201316970902
   Web of Science ®Google Scholar
• M Tourkmani A, J ALHarbi T, Rsheed AMB, et al. The impact of telemedicine on patients with uncontrolled type 2 diabetes mellitus during the COVID-19 pandemic in Saudi Arabia: findings and implications. J Telemed Telecare. 2021. doi:10.1177/1357633X20985763
   PubMed Web of Science ®Google Scholar
• Ghosh A, Gupta R, Misra A. Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: guidelines for physicians. Diabetes Metab Syndr. 2020;14(4). doi:10.1016/j.dsx.2020.04.001
   Web of Science ®Google Scholar
• Lauffenburger JC, Ghazinouri R, Jan S, et al. Impact of a novel pharmacist-delivered behavioral intervention for patients with poorly-controlled diabetes: the ENhancing outcomes through Goal Assessment and Generating Engagement in Diabetes Mellitus (ENGAGE-DM) pragmatic randomized trial. PLoS One. 2019;14(4):4. doi:10.1371/journal.pone.0214754
   Web of Science ®Google Scholar
• Jahangard-Rafsanjani Z, Sarayani A, Nosrati M, et al. Effect of a community pharmacist–delivered diabetes support program for patients receiving specialty medical care: a randomized controlled trial. Diabetes Educ. 2015;41(1):127–135. doi:10.1177/0145721714559132
   PubMed Web of Science ®Google Scholar
• Erku DA, Ayele AA, Mekuria AB, Belachew SA, Hailemeskel B, Tegegn HG. The impact of pharmacist-led medication therapy management on medication adherence in patients with type 2 diabetes mellitus: a randomized controlled study. Pharm Pract. 2017;15(3):1–7. doi:10.18549/PharmPract.2017.03.1026
   Google Scholar
• Arain MA, Ahmad A, Chiu V, Kembel L. Medication adherence support of an in-home electronic medication dispensing system for individuals living with chronic conditions: a pilot randomized controlled trial. BMC Geriatr. 2021;21(1):1–16. doi:10.1186/s12877-020-01979-w
   PubMed Web of Science ®Google Scholar
• Lyons I, Barber N, Raynor DK, Wei L. The Medicines Advice Service Evaluation (MASE): a randomised controlled trial of a pharmacist-led telephone based intervention designed to improve medication adherence. BMJ Qual Saf. 2016;25(10):759–769. doi:10.1136/bmjqs-2015-004670
   PubMed Web of Science ®Google Scholar
• Odegard PS, Christensen DB. MAP study: RCT of a medication adherence program for patients with type 2 diabetes. J Am Pharm Assoc. 2012;52(6):753–762. doi:10.1331/JAPhA.2012.11001
   Google Scholar
• O’Connor PJ, Schmittdiel JA, Pathak RD, et al. Randomized trial of telephone outreach to improve medication adherence and metabolic control in adults with diabetes. Diabetes Care. 2014;37(12):3317–3324. doi:10.2337/dc14-0596
   PubMed Web of Science ®Google Scholar
• Xin C, Xia Z, Jiang C, Lin M, Li G. Effect of pharmaceutical care on medication adherence of patients newly prescribed insulin therapy: a randomized controlled study. Patient Prefer Adherence. 2015;9:797–802. doi:10.2147/PPA.S84411
   PubMed Web of Science ®Google Scholar
• Antoine SL, Pieper D, Mathes T, Eikermann M. Improving the adherence of type 2 diabetes mellitus patients with pharmacy care: a systematic review of randomized controlled trials. BMC Endocr Disord. 2014;14:0–7. doi:10.1186/1472-6823-14-53
   Web of Science ®Google Scholar
• Peláez Bejarano A, Villar Santos P, Robustillo-Cortés MDLA, Sánchez Gómez E, Santos Rubio MD. Implementation of a novel home delivery service during pandemic. Eur J Hosp Pharm. 2021;28(e1):E120–E123. doi:10.1136/ejhpharm-2020-002500
   PubMedGoogle Scholar
• Killeen RM, Grindrod K, Ong SW. Innovations in practice: telepharmacy’s time has arrived. Can Pharm J. 2020;153(5):252–255. doi:10.1177/1715163520945732
   Web of Science ®Google Scholar
• McFarland R. Telepharmacy for remote hospital inpatients in north-west Queensland. J Telemed Telecare. 2017;23(10):861–865. doi:10.1177/1357633X17732367
   PubMed Web of Science ®Google Scholar
• Shane-McWhorter L, McAdam-Marx C, Lenert L, et al. Pharmacist-provided diabetes management and education via a telemonitoring program. J Am Pharm Assoc. 2015;55(5):516–526. doi:10.1331/JAPhA.2015.14285
   Google Scholar
• Zullig LL, Peterson ED, Bosworth HB. Ingredients of successful interventions to improve medication adherence. JAMA. 2013;310(24):2611–2612. doi:10.1001/jama.2013.282818
   PubMed Web of Science ®Google Scholar
• Yang YT, Kozhimannil KB. Medication abortion through telemedicine. Obstet Gynecol. 2016;127(2):313–316. doi:10.1097/AOG.0000000000001251
   PubMed Web of Science ®Google Scholar
• Schwamm LH, Chumbler N, Brown E, et al. Recommendations for the implementation of telehealth in cardiovascular and stroke care: a policy statement from the American heart association. Circulation. 2017;135(7):e24–e44. doi:10.1161/CIR.0000000000000475
   PubMed Web of Science ®Google Scholar
• Abimbola S, Keelan S, Everett M, et al. The medium, the message and the measure: a theory-driven review on the value of telehealth as a patient-facing digital health innovation. Health Econ Rev. 2019;9(1). doi:10.1186/s13561-019-0239-5
   PubMedGoogle Scholar
• Cohen LB, Taveira TH, Wu WC, Pirraglia PA. Pharmacist-led telehealth disease management program for patients with diabetes and depression. J Telemed Telecare. 2020;26(5). doi:10.1177/1357633X18822575
   PubMed Web of Science ®Google Scholar
• Clifton GD, Byer H, Heaton K, Haberman DJ, Gill H. Provision of pharmacy services to underserved populations via remote dispensing and two-way videoconferencing. Am J Health Pharm. 2003;60(24):2577–2582. doi:10.1093/ajhp/60.24.2577
   PubMed Web of Science ®Google Scholar
• Lam AY, Rose D. Telepharmacy services in an urban community health clinic system. J Am Pharm Assoc. 2009;49(5):652–659. doi:10.1331/JAPhA.2009.08128
   Google Scholar
• Margolis SA, Ypinazar VA. Tele-pharmacy in remote medical practice: the royal flying doctor service medical chest program. Rural Remote Health. 2008;8(2):937. doi:10.22605/rrh937
   PubMed Web of Science ®Google Scholar
• Aguiar PM, da Silva CHP, Chiann C, Dórea EL, Lyra DP, Storpirtis S. Pharmacist–physician collaborative care model for patients with uncontrolled type 2 diabetes in Brazil: results from a randomized controlled trial. J Eval Clin Pract. 2018;24(1):22–30. doi:10.1111/jep.12606
   PubMed Web of Science ®Google Scholar
• Chen JH, Ou HT, Lin TC, Lai ECC, Yang Kao YH. Pharmaceutical care of elderly patients with poorly controlled type 2 diabetes mellitus: a randomized controlled trial. Int J Clin Pharm. 2016;38(1):88–95. doi:10.1007/s11096-015-0210-4
   PubMed Web of Science ®Google Scholar
• Choudhry NK, Isaac T, Lauffenburger JC, et al. Effect of a remotely delivered tailored multicomponent approach to enhance medication taking for patients with hyperlipidemia, hypertension, and diabetes the STIC2IT cluster randomized clinical trial. JAMA Intern Med. 2018;178(9):1182. doi:10.1001/jamainternmed.2018.3189
   PubMed Web of Science ®Google Scholar
• McConnell M, Rogers W, Simeonova E, Wilson IB. Architecting process of care: a randomized controlled study evaluating the impact of providing nonadherence information and pharmacist assistance to physicians. Health Serv Res. 2020;55(1):136–145. doi:10.1111/1475-6773.13243
   PubMed Web of Science ®Google Scholar
• Jarab AS, Alqudah SG, Mukattash TL, Shattat G, Al-Qirim T. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan. J Manag Care Pharm. 2012;18(7):516–526. doi:10.18553/jmcp.2012.18.7.516
   PubMed Web of Science ®Google Scholar
• Khan YH, Alzarea AI, Alotaibi NH, et al. Evaluation of impact of a pharmacist-led educational campaign on disease knowledge, practices and medication adherence for type-2 diabetic patients: a prospective pre- and post-analysis. Int J Environ Res Public Health. 2022;19(16):10060. doi:10.3390/ijerph191610060
   PubMed Web of Science ®Google Scholar
• Lauffenburger JC, Lewey J, Jan S, et al. Effectiveness of targeted insulin-adherence interventions for glycemic control using predictive analytics among patients with type 2 diabetes: a randomized clinical trial. JAMA Netw open. 2019;2(3):e190657. doi:10.1001/jamanetworkopen.2019.0657
   PubMed Web of Science ®Google Scholar
• Lee JY, Wong CP, Tan CSS, Nasir NH, Lee SWH. Telemonitoring in fasting individuals with type 2 diabetes mellitus during ramadan: a prospective, randomised controlled study. Sci Rep. 2017;7(1). doi:10.1038/s41598-017-10564-y
   Google Scholar
• Mcfarland M, Davis K, Wallace J, et al. Use of home telehealth monitoring with active medication therapy management by clinical pharmacists in veterans with poorly controlled type 2 diabetes mellitus. Pharmacotherapy. 2012;32(5):420–426. doi:10.1002/j.1875-9114.2011.01038.x
   PubMed Web of Science ®Google Scholar
• Olesen C, Harbig P, Buus KM, Barat I, Damsgaard EM. Impact of pharmaceutical care on adherence, hospitalisations and mortality in elderly patients. Int J Clin Pharm. 2014;36(1):163–171. doi:10.1007/s11096-013-9898-1
   PubMed Web of Science ®Google Scholar
• Peasah SK, Granitz K, Vu M, Jacob B. Effectiveness of a student pharmacist–led telephone follow-up intervention to improve hemoglobin A1C in diabetic patients. J Pharm Pract. 2020;33(6):832–837. doi:10.1177/0897190019857409
   PubMed Web of Science ®Google Scholar
• Sarayani A, Mashayekhi M, Nosrati M, et al. Efficacy of a telephone-based intervention among patients with type-2 diabetes; a randomized controlled trial in pharmacy practice. Int J Clin Pharm. 2018;40(2):345–353. doi:10.1007/s11096-018-0593-0
   PubMed Web of Science ®Google Scholar
• Siaw MYL, Ko Y, Malone DC, et al. Impact of pharmacist-involved collaborative care on the clinical, humanistic and cost outcomes of high-risk patients with type 2 diabetes (IMPACT): a randomized controlled trial. J Clin Pharm Ther. 2017;42(4):475–482. doi:10.1111/jcpt.12536
   PubMed Web of Science ®Google Scholar